Welcome to our dedicated page for Veralto SEC filings (Ticker: VLTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Veralto's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Veralto's regulatory disclosures and financial reporting.
Veralto Corporation reported higher results for the first quarter of 2026. Sales rose 6.7% year-over-year to $1,422 million, with non-GAAP core sales growth of 1.9%. Operating profit margin was 23.8%, and adjusted operating profit margin was 25.1%.
Net earnings were $254 million, or $1.02 per diluted share, while adjusted net earnings were $266 million, or $1.07 per diluted share. Operating cash flow reached $182 million and non-GAAP free cash flow was $170 million.
Year-to-date capital allocation was about $1 billion, including approximately $620 million for the In-Situ and GlobalVision acquisitions and $300 million of share repurchases, equal to 1.3% of outstanding shares as of February 13, 2026. Veralto also launched a cost optimization program expected to incur charges of $85 to $105 million and deliver annual savings of $65 to $75 million by 2028. The company raised its 2026 adjusted EPS outlook to $4.20–$4.28 and now targets free cash flow conversion of about 100% of GAAP net earnings.
VLTO notice of proposed sale under Rule 144 for 10,000 shares held at Fidelity Brokerage Services LLC, dated 03/30/2026. The filing cites an option granted on 07/15/2023 as the source of the shares. It also lists a recent sale of 8,664 shares on 03/12/2026.
Veralto Corp disclosure: The Vanguard Group filed Amendment No. 4 to a Schedule 13G/A reporting 0 shares beneficially owned and 0% of Veralto Corp common stock. The filing explains an internal realignment on January 12, 2026 and states certain Vanguard subsidiaries will report separately in reliance on SEC Release No. 34-39538.
Veralto Corporation reported a strong 2025 driven by record revenue and cash generation. Total sales reached $5.5 billion, adjusted EPS was $3.90 (an increase of 10%), and free cash flow exceeded $1 billion. The company increased its dividend by 18% and authorized a $750 million share repurchase program while reporting $2.673 billion of total debt. Veralto described broad‑based growth across its two segments — Water Quality ($3.3B) and Product Quality & Innovation ($2.2B) — and reiterated expectations for continued core sales, margin and adjusted EPS growth in 2026.
Veralto Corporation is asking shareholders to vote at its 2026 virtual annual meeting on director elections, auditor ratification and an advisory say-on-pay resolution. Four Class III directors, including the CEO and independent chair, are nominated for one-year terms as part of a phased Board declassification.
The Board highlights strong 2025 performance with approximately $5.5 billion in revenue, core sales growth, margin expansion, double-digit adjusted EPS growth and robust cash flow, supported by the Veralto Enterprise System and increased growth investments.
Veralto emphasizes governance and sustainability, including an independent chair, fully independent key committees, elimination of supermajority voting, annual say-on-pay, pay-for-performance with most executive pay at risk, rigorous clawback and anti-hedging policies, climate and human capital goals, and a commitment to equal pay globally by 2030.
Trivedi Surekha reported acquisition or exercise transactions in this Form 4 filing.
Veralto Corp reported that SVP of Strategy & Sustainability Surekha Trivedi received new equity awards on March 1, 2026. She was granted 7,824 employee stock options and 2,310 shares of common stock through restricted stock units. The RSUs and options vest in two equal parts on the third and fourth anniversaries of the grant date, tying her compensation to Veralto’s long-term performance.
Veralto Corp Chief Accounting Officer Bernard M. Skeete reported equity awards and a small tax-related share disposition. On March 1, 2026, he received an employee stock option grant for 4,637 options at a price of $0.00 and a grant of 1,369 shares of common stock payable under restricted stock units.
According to the footnotes, one quarter of both the options and RSUs vest on each of the first, second, third, and fourth anniversaries of the March 1, 2026 grant date. On February 27, 2026, 103 shares of common stock were disposed of at $97.43 per share to satisfy tax obligations through a tax-withholding transaction, leaving 3,691 shares of common stock directly owned after that disposition and 5,060 shares following the later RSU grant.
Veralto Corp reported that SVP and Chief Financial Officer Sameer Ralhan acquired new equity awards. He received 24,774 employee stock options and a grant of 7,313 shares of common stock at a price of $0.00 per share as compensation awards.
According to the footnotes, the common stock grant represents restricted stock units payable solely in common stock. One half of the RSUs vest on each of the third and fourth anniversaries of the grant date, which is March 1, 2026. One half of the options become exercisable on each of the third and fourth anniversaries of the same grant date.
Veralto Corp senior vice president Melissa Kapity reported a mix of stock grants, option exercises, and share sales. On March 1, 2026, she received 15,213 employee stock options at an exercise price of $0 and 4,491 common shares as restricted stock units payable solely in stock. One half of these RSUs and one half of the options vest or become exercisable on each of the third and fourth anniversaries of the grant date.
On February 27, 2026, she exercised options covering 2,639 and 7,105 shares of common stock at an exercise price of $83.23 per share and then sold 14,840 shares of common stock in open-market transactions at $96.60 per share. After these transactions, she continued to hold common stock directly.